Experienced in Diverticular Disease

Mengtao Zhou

Key Laboratory Of Diagnosis And Treatment Of Severe Hepato Pancreatic Diseases Of ZheJiang Province, 
Wenzhou, CN 
Experienced in Diverticular Disease
Key Laboratory Of Diagnosis And Treatment Of Severe Hepato Pancreatic Diseases Of ZheJiang Province, 
Wenzhou, CN 
OverviewLocationsClinical Research

Overview

Mengtao Zhou practices in Wenzhou, China. Zhou is rated as an Experienced expert by MediFind in the treatment of Diverticular Disease. Their top areas of expertise are Acute Pancreatitis, Hereditary Pancreatitis, Pancreatic Cancer, Wilson Disease, and Islet Cell Transplantation.

Their clinical research consists of co-authoring 62 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 1 article in the study of Diverticular Disease.

Locations

Key Laboratory Of Diagnosis And Treatment Of Severe Hepato Pancreatic Diseases Of ZheJiang Province, Wenzhou, 325000, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

Clinical Study of Redirected Autologous T Cells With a Chimeric Antigen Receptor in Patients With Malignant Tumors
Clinical Study of Redirected Autologous T Cells With a Chimeric Antigen Receptor in Patients With Malignant Tumors
Enrollment Status: Unknown
Publish Date: October 08, 2020
Intervention Type: Genetic, Drug
Study Drugs: Fludarabine, Cyclophosphamide
Study Phase: Not Applicable

62 Total Publications

Pseudostellaria heterophylla Extract Polysaccharide H-1-2 Suppresses Pancreatic Cancer by Inhibiting Hypoxia-Induced AG2.
Pseudostellaria heterophylla Extract Polysaccharide H-1-2 Suppresses Pancreatic Cancer by Inhibiting Hypoxia-Induced AG2.
Journal: Molecular therapy oncolytics
Published: February 17, 2020

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Zhou's expertise for a condition
ConditionClose
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile